Literature DB >> 8180517

Gene therapy for vascular diseases.

K K Wu1, P Zoldhelyi, J T Willerson, X M Xu, D S Loose-Mitchell, L H Wang.   

Abstract

Gene transfer by virus- and liposome-mediated vectors has potential for treating genetic diseases, cancer, and cardiovascular diseases. In this article, we discuss the general principle and techniques for gene transfer and the specific issues facing therapy for vascular diseases. We also propose a strategy for using virus-mediated gene transfer to restore the vasoprotective function of the vascular wall, thereby preventing vascular thrombosis. Experimental data from ongoing work in our laboratories are presented to illustrate the importance of this approach in vascular gene transfer therapy.

Entities:  

Mesh:

Year:  1994        PMID: 8180517      PMCID: PMC325138     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  37 in total

1.  Receptor-mediated gene delivery and expression in vivo.

Authors:  G Y Wu; C H Wu
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

2.  High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors.

Authors:  J A Zwiebel; S M Freeman; P W Kantoff; K Cornetta; U S Ryan; W F Anderson
Journal:  Science       Date:  1989-01-13       Impact factor: 47.728

3.  Recombinant gene expression in vivo within endothelial cells of the arterial wall.

Authors:  E G Nabel; G Plautz; F M Boyce; J C Stanley; G J Nabel
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

4.  Implantation of vascular grafts lined with genetically modified endothelial cells.

Authors:  J M Wilson; L K Birinyi; R N Salomon; P Libby; A D Callow; R C Mulligan
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

5.  Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

6.  Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro.

Authors:  G Y Wu; C H Wu
Journal:  Biochemistry       Date:  1988-02-09       Impact factor: 3.162

7.  Seeding of intravascular stents with genetically engineered endothelial cells.

Authors:  D A Dichek; R F Neville; J A Zwiebel; S M Freeman; M B Leon; W F Anderson
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

8.  Regulation of PGI2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGI2 binding and stabilizing protein in human blood.

Authors:  A L Tsai; M J Hsu; W Patsch; K K Wu
Journal:  Biochim Biophys Acta       Date:  1991-12-06

9.  An alternative approach to somatic cell gene therapy.

Authors:  D St Louis; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

Authors:  D L DeWitt; W L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  2 in total

Review 1.  Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.

Authors:  W Casscells; J T Willerson
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

2.  Myocardial revascularization. Historical considerations.

Authors:  R J Hall
Journal:  Tex Heart Inst J       Date:  1994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.